85 related articles for article (PubMed ID: 9634854)
1. Engineering epidermal growth factor for enhanced mitogenic potency.
Reddy CC; Niyogi SK; Wells A; Wiley HS; Lauffenburger DA
Nat Biotechnol; 1996 Dec; 14(13):1696-9. PubMed ID: 9634854
[TBL] [Abstract][Full Text] [Related]
2. Receptor-mediated effects on ligand availability influence relative mitogenic potencies of epidermal growth factor and transforming growth factor alpha.
Reddy CC; Wells A; Lauffenburger DA
J Cell Physiol; 1996 Mar; 166(3):512-22. PubMed ID: 8600155
[TBL] [Abstract][Full Text] [Related]
3. Transforming growth factor-alpha short-circuits downregulation of the epidermal growth factor receptor.
Ouyang X; Gulliford T; Huang G; Epstein RJ
J Cell Physiol; 1999 Apr; 179(1):52-7. PubMed ID: 10082132
[TBL] [Abstract][Full Text] [Related]
4. EGF receptor-mediated, c-Src-dependent, activation of Stat5b is downregulated in mitogenically responsive hepatocytes.
Guren TK; Ødegård J; Abrahamsen H; Thoresen GH; Susa M; Andersson Y; Østby E; Christoffersen T
J Cell Physiol; 2003 Jul; 196(1):113-23. PubMed ID: 12767047
[TBL] [Abstract][Full Text] [Related]
5. Osteopontin-induced migration of human mammary epithelial cells involves activation of EGF receptor and multiple signal transduction pathways.
Tuck AB; Hota C; Wilson SM; Chambers AF
Oncogene; 2003 Feb; 22(8):1198-205. PubMed ID: 12606946
[TBL] [Abstract][Full Text] [Related]
6. Sprouty2 downregulation plays a pivotal role in mediating crosstalk between TGF-beta1 signaling and EGF as well as FGF receptor tyrosine kinase-ERK pathways in mesenchymal cells.
Ding W; Shi W; Bellusci S; Groffen J; Heisterkamp N; Minoo P; Warburton D
J Cell Physiol; 2007 Sep; 212(3):796-806. PubMed ID: 17516543
[TBL] [Abstract][Full Text] [Related]
7. Proliferative response of fibroblasts expressing internalization-deficient epidermal growth factor (EGF) receptors is altered via differential EGF depletion effect.
Reddy CC; Wells A; Lauffenburger DA
Biotechnol Prog; 1994; 10(4):377-84. PubMed ID: 7765094
[TBL] [Abstract][Full Text] [Related]
8. Ligand depletion negatively controls the mitogenic activity of epidermal growth factor.
van de Poll ML; van Rotterdam W; Gadellaa MM; Jacobs-Oomen S; van Zoelen EJ
Exp Cell Res; 2005 Apr; 304(2):630-41. PubMed ID: 15748906
[TBL] [Abstract][Full Text] [Related]
9. Blockade of epidermal growth factor receptor signaling leads to inhibition of renal cell carcinoma growth in the bone of nude mice.
Weber KL; Doucet M; Price JE; Baker C; Kim SJ; Fidler IJ
Cancer Res; 2003 Jun; 63(11):2940-7. PubMed ID: 12782601
[TBL] [Abstract][Full Text] [Related]
10. Tumor necrosis factor-alpha-stimulated membrane type 1-matrix metalloproteinase production is modulated by epidermal growth factor receptor signaling in human gingival fibroblasts.
Smith PC; Guerrero J; Tobar N; Cáceres M; González MJ; Martínez J
J Periodontal Res; 2009 Feb; 44(1):73-80. PubMed ID: 19515020
[TBL] [Abstract][Full Text] [Related]
11. Complex post-transcriptional regulation of EGF-receptor expression by EGF and TGF-alpha in human prostate cancer cells.
Seth D; Shaw K; Jazayeri J; Leedman PJ
Br J Cancer; 1999 May; 80(5-6):657-69. PubMed ID: 10360641
[TBL] [Abstract][Full Text] [Related]
12. LOT1 is a growth suppressor gene down-regulated by the epidermal growth factor receptor ligands and encodes a nuclear zinc-finger protein.
Abdollahi A; Bao R; Hamilton TC
Oncogene; 1999 Nov; 18(47):6477-87. PubMed ID: 10597250
[TBL] [Abstract][Full Text] [Related]
13. Regulation by ceramide of epidermal growth factor signal transduction and mitogenesis in cell lines overexpressing the growth factor receptor.
Gallardo G; Tabraue C; Quintana J; López-Blanco F; Cabrera J; Díaz R; Estévez F; Ruiz de Galarreta CM; Fanjul LF; Santana P
Cell Mol Biol (Noisy-le-grand); 2000 Nov; 46(7):1305-12. PubMed ID: 11075960
[TBL] [Abstract][Full Text] [Related]
14. Role of epidermal growth factor receptor in basal and stimulated colonic epithelial cell migration in vitro.
Wilson AJ; Gibson PR
Exp Cell Res; 1999 Jul; 250(1):187-96. PubMed ID: 10388532
[TBL] [Abstract][Full Text] [Related]
15. Differential regulation of EGF-like growth factor genes in human keratinocytes.
Stoll SW; Elder JT
Biochem Biophys Res Commun; 1999 Nov; 265(1):214-21. PubMed ID: 10548517
[TBL] [Abstract][Full Text] [Related]
16. An intermediary role of proHB-EGF shedding in growth factor-induced c-Myc gene expression.
Nanba D; Inoue H; Shigemi Y; Shirakata Y; Hashimoto K; Higashiyama S
J Cell Physiol; 2008 Feb; 214(2):465-73. PubMed ID: 17674363
[TBL] [Abstract][Full Text] [Related]
17. EGF, TGF alpha, AR and HB-EGF are autocrine growth factors for human bladder carcinoma cell lines.
Ruck A; Paulie S
Anticancer Res; 1998; 18(3A):1447-52. PubMed ID: 9673354
[TBL] [Abstract][Full Text] [Related]
18. Desmoid cell motility is induced in vitro by rhEGF.
Joyner DE; Trang SH; Damron TA; Aboulafia AJ; Cummings JE; Randall RL
J Orthop Res; 2009 Sep; 27(9):1258-62. PubMed ID: 19242968
[TBL] [Abstract][Full Text] [Related]
19. Stimulation of mitogenic pathways through kinase-impaired mutants of the epidermal growth factor receptor.
Ewald JA; Coker KJ; Price JO; Staros JV; Guyer CA
Exp Cell Res; 2001 Aug; 268(2):262-73. PubMed ID: 11478852
[TBL] [Abstract][Full Text] [Related]
20. Heparin-binding EGF-like growth factor expression increases selectively in bladder smooth muscle in response to lower urinary tract obstruction.
Borer JG; Park JM; Atala A; Nguyen HT; Adam RM; Retik AB; Freeman MR
Lab Invest; 1999 Nov; 79(11):1335-45. PubMed ID: 10576204
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]